References

No references inside the corpus for this window.

Cited by

• 2017Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure175 cited
• 2021COVID-19 and the collapse of global trade: building an effective public health response113 cited
• 2016Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol100 cited
• 2020Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran98 cited
• 2015Brain and other nervous system disorders across the lifespan — global challenges and opportunities94 cited
• 2019Soft power and global health: the sustainable development goals (SDGs) era health agendas of the G7, G20 and BRICS93 cited
• 2017The Impact of Policies to Reduce trans Fat Consumption: A Systematic Review of the Evidence91 cited
• 2011Cardiovascular Disease and the Changing Face of Global Public Health: A Focus on Low and Middle Income Countries86 cited
• 2017Financing national non-communicable disease responses80 cited
• 2014The role of law and governance reform in the global response to non-communicable diseases78 cited
• 2019Non-Communicable Diseases and Urbanization in African Cities: A Narrative Review68 cited
• 2012Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)67 cited